Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Effects of Fibroblast Growth Factor 21 Serum Level on Clinicopathological Findings in Papillary Thyroid Carcinoma
Farzaneh Sadat Minoo
Farzaneh Sadat Minoo

Associate Professor of Nephrology

Department Internal Medicine

School of Medicine

Imam Khomeini Hospital Complex

Tehran University of Medical Sciences

All Documents
1. Analysis of Prevalence and Trends in the Biopsy-Proven Native Kidney Diseases in Iranian Population: A 12-Year Survey From a Referral Center, Iranian Journal of Pathology (2023)
2. Evaluation of Laboratory Values Affecting Mortality of End-Stage Renal Disease Patients: A Competing Risks Approach, BMC Nephrology (2023)
3. Spectrum and Distribution of Biopsy-Proven Kidney Diseases: A 12-Year Survey of a Single Center in Iran, Saudi Journal of Kidney Diseases and Transplantation (2023)
4. Expression of Programmed Cell Death 1 and Helios Genes Correlates With Rs872071a>G and Rs12203592c>T Single-Nucleotide Polymorphisms of Interferon Regulatory Factor 4 in Patients With T-Cell-Mediated Rejection of Renal Allograft, Experimental and Clinical Transplantation (2022)
5. The Correlation Between Copeptin and Volume Status in Chronic Hemodialysis Patients, Iranian Journal of Kidney Diseases (2022)
6. Comparing Irf-4 Gene Expression Between Acute T Cell-Mediated Rejection and Stable Renal Transplant Recipients, Iranian Journal of Kidney Diseases (2021)
7. Identifying Influential Prognostic Factors of Death Hazard Rates in Patients With Chronic Kidney Disease (Ckd) Using Weibull Model With Non-Constant Shape Parameter, Journal of Biostatistics and Epidemiology (2021)
8. Association Between Pre-Transplant Magnesemia and Post-Transplant Dysglycemia in Kidney Transplant Recipients, International Journal of Endocrinology and Metabolism (2020)
9. Evaluation of the Effect of High Dose Intravenous Vitamin C on Delayed Allograft Function in Deceased Donor Kidney Transplantation: A Preliminary Report, Renal Replacement Therapy (2020)
10. Resistant Hypertension, Case Based Approach to Diagnosis and Management: Case Report, Tehran University Medical Journal (2020)
11. Does Fibroblast Growth Factor 23 Correlates With Volume Status in Hemodialysis Patients?, Journal of Nephropathology (2019)
12. Impact of Fibroblast Growth Factor-23 on Blood Pressure and Pulse Pressure in Hemodialysis Patients; a Multicenter Study, Journal of Nephropathology (2019)
13. Investigating the Relationship Between Blood Pressure and Serum Fgf23 Level in Patients Undergoing Hemodialysis in Guilan Province, a Cross Sectional Study, Iranian Journal of Kidney Diseases (2019)
14. Comparison of Body Composition Assessed by Multi-Frequency Segmental Bioelectrical Impedance Analysis and Dual Energy X-Ray Absorptiometry in Hemodialysis Patients, Nephro-Urology Monthly (2018)
15. The Association of Fibroblast Growth Factor-23 With Mineral Factors (Ca, P, and Mg), Parathyroid Hormone, and 25-Hydroxyvitamin D in Hemodialysis Patients: A Multicenter Study, Nephro-Urology Monthly (2018)
16. Prevention of Contrast-Induced Nephropathy With Oxygen Supplementation a Randomized Controlled Trial, Iranian Journal of Kidney Diseases (2016)